The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients

Journal of Clinical Lipidology

Volumn 10, Issue 5, 2016, Pages 1129-1136.e3

  Béliard, Sophie ^a,b,c   Millier, Aurélie ^d   Carreau, Valérie ^e   Carrié, Alain ^e   Moulin, Philippe ^f   Fredenrich, Alexandre ^g   Farnier, Michel ^h   Luc, Gérald ⁱ   Rosenbaum, David ^e   Toumi, Mondher ^a   Bruckert, Eric ^e   Angoulvant, D ^j   Beliard S ^j   Boccara, F ^j   Bruckert, E ^j   Durlach, V ^j   Farnier, M ^j   Ferrieres J ^j   Hankard, R ^j   Krempf, M ^j   Lalau, J D ^j   Luc, G ^j   Moulin, P ^j   Paillard, F ^j   Peretti, N ^j   Pradignac, A ^j   Pucheu, Y ^j   Tounian, P ^j   Verges B ^j   Ziegler, O ^j   more..

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d CREATIV CEUTICAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Louis Pradel Cardiology Hospital   (France)

^g PASTEUR HOSPITAL   (France)

^h Point Medical   (France)

ⁱ UNIV LILLE   (France)

^j Point Médical ^*

more..

Author keywords

Cardiovascular risk; Heterozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemia; LDL cholesterol

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; HYPOCHOLESTEROLEMIC AGENT;

ADULT; APHERESIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CAROTID PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SMOKING; XANTHOMA; AGED; ATHEROSCLEROTIC PLAQUE; BLOOD; CARDIOVASCULAR DISEASES; CAROTID ARTERY; COMPLICATION; FRANCE; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84997818384     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2016.06.007     Document Type: Article

References (24)

1. 1 Nordestgaard, B.G., Chapman, M.J., Humphries, S.E., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J 34 (2013), 3478–3490a.
2. 2 Farnier, M., Bruckert, E., Boileau, C., Krempf, M., Nouvelle société française d'athérosclérose. Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: guidelines from the New French Society of Atherosclerosis (NSFA). Presse Med 42:6 Pt 1 (2013), 930–950.
3. 3 Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 142 (1999), 105–112.
4. 4 Walma, E.P., Visseren, F.L., Jukema, J.W., et al. The practice guideline ‘Diagnosis and treatment of familial hypercholesterolaemia’ of the Dutch Health Care Insurance Board. Ned Tijdschr Geneeskd, 150, 2006, 18e23.
5. 5 Ned, R.M., Sijbrands, E., Cascade screening for familial hypercholesterolemia (FH). PLoS Curr, 3, 2011, RRN1238.
6. 6 Nherera, L., Marks, D., Minhas, R., Thorogood, M., Humphries, S.E., Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart 97:14 (2011), 1175–1181.
7. 7 Benn, M., Watts, G.F., Tybjaerg-Hansen, A., Nordestgaard, B.G., Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 97 (2012), 3956–3964.
8. 8 Graham, I., Atar, D., Borch-Johnsen, K., et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 28 (2007), 2375–2414.
9. 9 Stone, N.J., Robinson, J.G., Lichtenstein, A.H., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:25 Pt B (2014), 2889–2934.
10. 10 Goldberg, A.C., Hopkins, P.N., Toth, P.P., et al., National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 5:3 Suppl (2011), S1–S8.
11. 11 Robinson, J.G., Goldberg, A.C., National Lipid Association Expert Panel on Familial Hypercholesterolemia. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 5:3 Suppl (2011), S18–S29.
12. 12 Robinson, J.G., Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Manag Care Pharm 19:2 (2013), 139–149.
13. 13 Mata, P., Alonso, R., Ruiz, A., et al. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document]. [Article in Spanish] Semergen 41:1 (2015), 24–33.
14. 14 Nordestgaard, B.G., Chapman, M.J., Ray, K., et al., European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31:23 (2010), 2844–2853.
15. 15 National Collaborating Centre for Primary Care (UK). Identification and Management of Familial Hypercholesterolaemia (FH) [Internet]. 2008, Royal College of General Practitioners (UK), London National Institute for Health and Clinical Excellence: Guidance.
16. 16 Béliard, S., Carreau, V., Carrié, A., et al. Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects. Atherosclerosis 234:1 (2014), 136–141.
17. 17 Wierzbicki, A.S., Humphries, S.E., Minhas, R., Familial hypercholesterolaemia: summary of NICE guidance. BMJ, 337, 2008, a1095.
18. 18 Alonso, R., Andres, E., Mata, N., et al., SAFEHEART Investigators. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation. J Am Coll Cardiol 63:19 (2014), 1982–1989.
19. 19 Thanassoulis, G.1, Campbell, C.Y., Owens, D.S., et al., CHARGE Extracoronary Calcium Working Group. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 368:6 (2013), 503–512.
20. 20 Jansen, A.C., van Aalst-Cohen, E.S., Tanck, M.W., et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med 256:6 (2004), 482–490.
21. 21 Giral, P., Bruckert, E., Dairou, F., et al. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress tests. Am J Cardiol 84:1 (1999), 14–17.
22. 22 Fernández-Friera, L., Peñalvo, J.L., Fernández-Ortiz, A., et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation 131:24 (2015), 2104–2113.
23. 23 Högberg, D., Kragsterman, B., Björck, M., Tjärnström, J., Wanhainen, A., Carotid artery atherosclerosis among 65-year-old Swedish men - a population-based screening study. Eur J Vasc Endovasc Surg 48:1 (2014), 5–10.
24. 24 Hoeg, J.M., Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 77 (1996), 575–580.